×
English
हिंदी
ગુજરાતી
Home
My Feed
Remove Ads
Get Premium Content
Go Pro @₹99
Loan Against Mutual Fund
Apply Now
Credit Cards
Instant Loans
Apply Now
Credit Score
Refer & Earn ₹500
Refer Now
Finance Tracker
Learning Curve
Fixed Deposits
Business Loan
Vouchers
Markets
Markets
FII & DII Activity
Corporate Action
Research Advice
Earnings
Technical Trends
Stock Deals
Intraday Large Deals
Bonds
Webinar
Pre Market
Stock Scanner
Sector Analysis
Unlisted Shares
Stock Updates
PRO Stock Lists
Monsoon Tracker
Seasonality Analysis
Crypto Dashboard
Web Stories
Tax Calculator
Forum
Gold Rate
Silver Rate
IFSC Code Finder
Storyboard18
IPO
Economic Indicators
Economic Calendar
Global Markets
US Markets
ETFs
Indian Indices
News
News
Tech/Startups
Auto
Research
Opinion
Politics
Personal Finance
EPF Guide
Real Estate
Portfolio
Watchlist
Personal Finance
Personal Finance
Loans
Fixed Deposit Comparison
Fixed Deposit Interest Calculator
Moneycontrol - SecureNow Health Insurance ratings
Mutual Funds
Mutual Funds
Performance Tracker
Top ranked funds
My Portfolio
Top performing Categories
Forum
New Fund Offers
MF Simplified
Commodities
Mutual Funds
Gold Rate
Silver Rate
Currencies
Cryptocurrency
Media
Live TV & Shows
Video
Podcast
Photos
Invest Now
Trade like Experts
Invest in Unlisted Shares
Specials
Pharma Industry Conclave
Unlocking opportunities in Metal and Mining
#MFSummit2025
Advanced Technical Charts
International
Get App
Be a
Pro
Home
PRO
Markets
News
Budget 2026
Editor’s Picks
Tech
India
Learning Curve
Portfolio
Watchlist
Commodities
MF
PF
Forum
Videos
you are here:
Home
News
Dr Reddy Laboratories
Dr Reddy Laboratories
Dr Reddy’s denies report of cutting workforce costs by 25%, calls in 'factually incorrect'
CLSA selects Apollo Hospitals as top pick, says India's pharma set to outpace US growth
Dr Reddy's Q2 results: Net profit falls 15% to Rs 1,255 crore
Why everyone is not convinced about Dr Reddy’s latest acquisition
Nestle India, Dr Reddy's to form JV for nutraceutical brands in India, other agreed territories
Pharma Sector set for gains: Dr Reddy's Lab sees significant long position build-up
Torrent Pharma acquires four brands from Dr Reddy’s Lab
Dr Reddy’s Q2 Results Preview: Revenue expected to increase 4-5%, PAT to decline 15%
Dr Reddy's looks to cut greenhouse gas emissions by 55 percent in 10 years
Dr Reddy's Labs sells rights of cloderm cream to EPI Health LLC
Dr Reddy's arm sells specialty skin cream Cloderm to EPI Health
Markets@Moneycontrol: Nifty likely to open higher; top 3 stocks which could give 7-9% return
Dr.Reddys bullish about better sales in Europe in FY19
Dr Reddy's recalls over 80,000 bottles of Atorvastatin from US
New draft pharma policy will reduce risks like generalisation of mkt: JM Financial
Dr Reddy's likely to divest Penicillin assets in US: Sources
US law firm files class action lawsuit against Dr Reddy's for misleading statements
Hold Dr Reddy's Laboratories; target of Rs 2450: Axis Direct
What's In A Name? Registration of surnames as trademark
Hold Dr Reddys Laboratories: Ventura Securities
Kronos Drives Workforce Compliance And Productivity At Dr. Reddy's
Unsure of how biz will shape up in German mkt: Dr Reddy's
Home
Markets
Loans
SPIN
2
WIN
News
Portfolio